Reply to M.S. Daniels et al

Affiliations

Comment

Matthew B Yurgelun et al. J Clin Oncol. 2017.

. 2017 Aug 1;35(22):2588-2589.

doi: 10.1200/JCO.2017.73.3840. Epub 2017 May 16.

¹ Matthew B. Yurgelun and Sapna Syngal, Dana-Farber Cancer Institute, Harvard Medical School, and Brigham & Women's Hospital, Boston, MA.

No abstract available

Comment on

Cancer Susceptibility Gene Mutations in Individuals With Colorectal Cancer.
Yurgelun MB, Kulke MH, Fuchs CS, Allen BA, Uno H, Hornick JL, Ukaegbu CI, Brais LK, McNamara PG, Mayer RJ, Schrag D, Meyerhardt JA, Ng K, Kidd J, Singh N, Hartman AR, Wenstrup RJ, Syngal S. Yurgelun MB, et al. J Clin Oncol. 2017 Apr 1;35(10):1086-1095. doi: 10.1200/JCO.2016.71.0012. Epub 2017 Jan 30. J Clin Oncol. 2017. PMID: 28135145 Free PMC article.
Frequency of Germline BRCA1/2 Mutations in Unselected Patients With Colorectal Cancer.
Daniels MS, Bannon SA, Mork ME. Daniels MS, et al. J Clin Oncol. 2017 Aug 1;35(22):2588. doi: 10.1200/JCO.2017.72.7222. Epub 2017 May 16. J Clin Oncol. 2017. PMID: 28510492 No abstract available.